probably.
But the size of the potential market that cardiocel and other applications of adapt technology can be used for, and has a very good chance of becoming the product of choice.
There are in excess of 200 thousand cardiothoracic procedures performed in the USA that are all potential uses of cardiocel ( I recall reading somewhere that patches were used to close pericardium, so cases that don't require a patch could end up requiring one). We may not gain complete uptake by all for all procedures, but there is every possibility that we can.
Selling 200 000+ patches to the US each year for cardiothoracic uses alone...... yeah, I may be dreaming - almost delusional, but in the absence of any evidence that shows that we can not achieve this, I will continue to dream of what could be (and be happy if we only get part of the way).
Cormatrix reported selling to almost 850 centres across the states..... I don't see why AHZ can not achieve the same, with a product reported to be of superior quality.
Dreaming on!
- Forums
- ASX - By Stock
- Quarterly
probably. But the size of the potential market that cardiocel...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$14.25 |
Change
0.000(0.00%) |
Mkt cap ! $301.2M |
Open | High | Low | Value | Volume |
$14.20 | $14.76 | $13.70 | $355.0K | 25.04K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 988 | $14.25 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.99 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 988 | 14.250 |
1 | 499 | 14.150 |
2 | 700 | 14.050 |
1 | 113 | 14.000 |
1 | 1000 | 13.900 |
Price($) | Vol. | No. |
---|---|---|
14.990 | 1000 | 1 |
15.150 | 149 | 1 |
15.500 | 44 | 1 |
15.700 | 277 | 1 |
15.880 | 250 | 1 |
Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |